2502.T: Asahi Group Holdings, Ltd. Stock Live Price Graph
About the company
Asahi Group Holdings, Ltd. is a Japanese conglomerate that globally produces and distributes a wide array of alcoholic and non-alcoholic beverages, along with various food products. The company's business activities are structured across several divisions: Alcohol Beverages, Soft Drinks, Food, Overseas operations, and an "Others" segment. Its alcoholic product range includes imported and non-alcoholic beers, a selection of wines, shochu, whiskey, ready-to-drink options, happoshu, and spirits. For non-alcoholic refreshment, Asahi offers ciders, sparkling waters, coffees, teas, lactic acid drinks, bottled waters, sports drinks, and fruit juices. The food sector encompasses confectionery, health supplements, yeast extracts, infant formula and baby foods, skincare items, and an extensive line of freeze-dried meals such as miso, soups, porridges, and curries. These diverse goods are marketed under numerous well-known brands, including Asahi Super Dry, Mitsuya Cider, Wonda, Calpis, Peroni Nastro Azzurro, and Pilsner Urquell, among many others. In addition to manufacturing, the group operates restaurants and engages in the production of fertilizers, as well as microbiological and biochemical products. Established in Tokyo, Japan, in 1889 as Asahi Breweries, Ltd., the company officially changed its name to Asahi Group Holdings, Ltd. in July 2011.
Company profile
Market News & Analysis
Target Price
No analyst target price data is available for this instrument.
Dividend History
Cash dividends
| Payment | Gross / share | Net / share | Yield | Per 1,000 TRY |
|---|---|---|---|---|
| - | $26 | $26 | 3.42% | - |
| - | $26 | $26 | 3.15% | - |
| - | $26 | $26 | 2.79% | - |
| - | $27 | $27 | 2.94% | - |
| - | $65.9999 | $65.9999 | 2.28% | - |
| - | $65 | $65 | 2.31% | - |
| - | $56 | $56 | 2.02% | - |
| - | $56 | $56 | 2.73% | - |
| - | $55 | $55 | 2.44% | - |
| - | $55 | $55 | 2.43% | - |
| - | $54 | $54 | 2.06% | - |
| - | $53 | $53 | 2.47% | - |
| - | $53 | $53 | 2.73% | - |
| - | $48 | $48 | 1.99% | - |
| - | $52 | $52 | 2.19% | - |
| - | $54 | $54 | 2.42% | - |
| - | $45 | $45 | 1.59% | - |
| - | $45 | $45 | 1.33% | - |
| - | $30 | $30 | 1.36% | - |
| - | $28 | $28 | 1.46% | - |
| - | $26 | $26 | 1.58% | - |
| - | $26 | $26 | 1.33% | - |
| - | $24 | $24 | 1.18% | - |
| - | $23 | $23 | 1.18% | - |
| - | $22 | $22 | 1.38% | - |
| - | $21.5 | $21.5 | 1.45% | - |
| - | $21.5 | $21.5 | 1.53% | - |
| - | $14 | $14 | 1.51% | - |
| - | $14 | $14 | 1.66% | - |
| - | $13.5 | $13.5 | 1.48% | - |
| - | $11.5 | $11.5 | 1.49% | - |
| - | $12.5 | $12.5 | 1.45% | - |
| - | $10.5 | $10.5 | 1.36% | - |
| - | $11 | $11 | 1.22% | - |
| - | $10 | $10 | 1.55% | - |
| - | $10.5 | $10.5 | 1.32% | - |
| - | $9.5 | $9.5 | 0.96% | - |
| - | $9.5 | $9.5 | 0.96% | - |
| - | $9.5 | $9.5 | 1.04% | - |
| - | $10.5 | $10.5 | 1.01% | - |
| - | $8.5 | $8.5 | 1.13% | - |
| - | $9.5 | $9.5 | 1.16% | - |
| - | $7.5 | $7.5 | 1.15% | - |
| - | $7.5 | $7.5 | 1.18% | - |
| - | $7.5 | $7.5 | 1.16% | - |
| - | $6.5 | $6.5 | 1.38% | - |
| - | $6.5 | $6.5 | 2.66% | - |
| - | $13 | $13 | 1.68% | - |
| - | $1 | $1 | 0.60% | - |
| - | $6 | $6 | 0.86% | - |
| - | $6 | $6 | 1.01% | - |
| - | $6 | $6 | 0.47% | - |
What Is 2502.T? Live 2502.T Prices and Analysis
2502.T, also known as Takeda Pharmaceutical Company Limited, is a prominent global biopharmaceutical firm based in Japan. It specializes in research, development, manufacturing, and marketing of a wide range of pharmaceutical products, focusing on areas such as oncology, gastroenterology, neuroscience, and rare diseases. Given its extensive product portfolio and commitment to innovation, Takeda plays a significant role in the healthcare sector, making it a noteworthy consideration for investors.
As a publicly traded company, 2502.T garners attention from investors and analysts alike, particularly due to its influence on the pharmaceutical industry and the overall market sentiment surrounding healthcare stocks. Understanding the financial health and market position of Takeda is crucial for potential investors looking to navigate the complexities of the stock market.
Market Context
2502.T is traded on the Tokyo Stock Exchange, where it is subject to international trading dynamics. The pricing of Takeda's stock is influenced by various factors, including currency fluctuations, particularly the exchange rate between the Japanese Yen and the US Dollar. Given the volatility often seen in pharmaceutical stocks, particularly around earnings reports and regulatory approvals, investors must stay informed about market trends and investor sentiment.
Why Do 2502.T Prices Rise or Fall?
The stock price of 2502.T can be influenced by a multitude of factors, both fundamental and external. Understanding these drivers is essential for investors looking to anticipate potential price movements.
- Earnings Reports: Quarterly earnings significantly impact stock prices, as they provide insights into the company's financial performance.
- Drug Approvals: Regulatory approvals for new drugs can lead to substantial price increases due to anticipated revenue growth.
- Market Competition: The introduction of competing drugs can adversely affect Takeda's market share and pricing power.
- Global Health Trends: Changes in healthcare policies and public health crises can influence demand for Takeda's products.
- Research and Development Outcomes: Positive results from clinical trials can boost investor confidence and stock prices.
- Economic Indicators: Broader economic trends, including inflation rates and employment data, can impact investor sentiment in the healthcare sector.
- Dividends: Changes in dividend policy can affect investor perception and stock attractiveness.
- Market Sentiment: General investor sentiment towards the pharmaceutical industry can lead to volatility in stock prices.
Each of these factors can contribute to the overall volatility of 2502.T, necessitating careful analysis by investors.
Why Is Live 2502.T Price Tracking Important?
Keeping track of the live price of 2502.T is crucial for investors aiming to make informed trading decisions. Real-time price data allows investors to gauge market sentiment and identify potential entry and exit points.
- Timely Information: Stay updated with real-time price movements which can influence trading strategies.
- Market Analysis: Live price tracking aids in analyzing trends and patterns in stock behavior.
- Risk Management: Understanding price volatility helps in managing investment risks effectively.
- Investment Timing: Identifying optimal moments to buy or sell based on live price changes.
- Performance Monitoring: Track the performance of your investment against market benchmarks.
What Should You Consider When Trading / Investing in 2502.T?
Investing in 2502.T, like any other stock, carries inherent risks that investors should consider. Factors such as macroeconomic data, industry trends, and company-specific news are crucial to evaluate before making trading decisions.
Additionally, it's important to be aware of volatility warnings, particularly surrounding earnings announcements or significant drug trial results, which can lead to rapid price fluctuations.
What Can You Find on the Investvio 2502.T Page?
- Live price updates for 2502.T.
- Comprehensive charts showcasing historical price trends.
- Technical analysis tools to assist in market predictions.
- Latest news and updates regarding Takeda Pharmaceutical.
- Detailed information on earnings, dividends, and P/E ratios.
In conclusion, the Investvio page for 2502.T serves as a valuable resource for investors looking to stay informed and make educated decisions regarding their investments in Takeda Pharmaceutical Company Limited.